安慰剂-话题@MedSci

#安慰剂#

133篇内容 | 4110人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1304323, encodeId=3c91130432372, content=<a href='/topic/show?id=81724580886' target=_blank style='color:#2F92EE;'>#安慰剂#</a>, objectTitle=NEJM：对于单纯性皮肤脓肿，复方新诺明优于安慰剂治疗, objectType=article, longId=64084, objectId=fa956408434, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa956408434, replyNumber=0, likeNumber=64, createdTime=2016-03-04, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa956408434, moduleTitle=NEJM：对于单纯性皮肤脓肿，复方新诺明优于安慰剂治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa956408434)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304322, encodeId=608613043227d, content=<a href='/topic/show?id=81724580886' target=_blank style='color:#2F92EE;'>#安慰剂#</a>, objectTitle=安慰剂效应：不仅仅是安慰，可能具有一定的客观效应, objectType=article, longId=63143, objectId=8f7d631436f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f7d631436f, replyNumber=0, likeNumber=79, createdTime=2016-02-12, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f7d631436f, moduleTitle=安慰剂效应：不仅仅是安慰，可能具有一定的客观效应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f7d631436f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304321, encodeId=5e12130432171, content=<a href='/topic/show?id=81724580886' target=_blank style='color:#2F92EE;'>#安慰剂#</a>, objectTitle=Nature：止痛剂药物研发面临安慰剂效应窘境, objectType=article, longId=57104, objectId=02c35e1045e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02c35e1045e, replyNumber=0, likeNumber=74, createdTime=2015-10-13, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02c35e1045e, moduleTitle=Nature：止痛剂药物研发面临安慰剂效应窘境, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02c35e1045e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304320, encodeId=28ef1304320d0, content=<a href='/topic/show?id=81724580886' target=_blank style='color:#2F92EE;'>#安慰剂#</a>, objectTitle=医生应该多使用安慰剂吗？, objectType=article, longId=45138, objectId=61954513866, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61954513866, replyNumber=0, likeNumber=71, createdTime=2015-01-09, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61954513866, moduleTitle=医生应该多使用安慰剂吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61954513866)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304319, encodeId=df1d1304319d8, content=<a href='/topic/show?id=81724580886' target=_blank style='color:#2F92EE;'>#安慰剂#</a>, objectTitle=RECOURSE试验III期：TAS-102对比安慰剂治疗已给予更佳支持治疗且能耐受标准化疗的mCRC患者, objectType=article, longId=43695, objectId=811c4369574, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=811c4369574, replyNumber=0, likeNumber=74, createdTime=2014-12-10, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=811c4369574, moduleTitle=RECOURSE试验III期：TAS-102对比安慰剂治疗已给予更佳支持治疗且能耐受标准化疗的mCRC患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=811c4369574)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304318, encodeId=e9fa130431806, content=<a href='/topic/show?id=81724580886' target=_blank style='color:#2F92EE;'>#安慰剂#</a>, objectTitle=FDA坚持安慰剂对照在埃博拉药物研制中不可省略, objectType=article, longId=42476, objectId=f175424e6fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f175424e6fe, replyNumber=0, likeNumber=82, createdTime=2014-11-13, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f175424e6fe, moduleTitle=FDA坚持安慰剂对照在埃博拉药物研制中不可省略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f175424e6fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304317, encodeId=8c13130431e4a, content=<a href='/topic/show?id=81724580886' target=_blank style='color:#2F92EE;'>#安慰剂#</a>, objectTitle=SCIENCE：揭开安慰剂治疗的假面, objectType=article, longId=41105, objectId=064c41105eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=064c41105eb, replyNumber=0, likeNumber=91, createdTime=2014-10-12, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=064c41105eb, moduleTitle=SCIENCE：揭开安慰剂治疗的假面, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=064c41105eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304316, encodeId=5211130431698, content=<a href='/topic/show?id=81724580886' target=_blank style='color:#2F92EE;'>#安慰剂#</a>, objectTitle=中医药随机对照临床试验安慰剂选择的探讨, objectType=article, longId=38881, objectId=90ca38881e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90ca38881e6, replyNumber=0, likeNumber=0, createdTime=2014-08-10, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90ca38881e6, moduleTitle=中医药随机对照临床试验安慰剂选择的探讨, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90ca38881e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304315, encodeId=fa0713043150d, content=<a href='/topic/show?id=81724580886' target=_blank style='color:#2F92EE;'>#安慰剂#</a>, objectTitle=小知识：反安慰剂效应临床研究中魔鬼, objectType=article, longId=34693, objectId=9f3a34693ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f3a34693ef, replyNumber=0, likeNumber=74, createdTime=2014-05-15, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f3a34693ef, moduleTitle=小知识：反安慰剂效应临床研究中魔鬼, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f3a34693ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304314, encodeId=a1eb1304314e4, content=<a href='/topic/show?id=81724580886' target=_blank style='color:#2F92EE;'>#安慰剂#</a>, objectTitle=Lancet Neurol：多西环素治疗克-雅氏病疗效与安慰剂类似, objectType=article, longId=29839, objectId=20f329839bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20f329839bf, replyNumber=0, likeNumber=88, createdTime=2014-01-25, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20f329839bf, moduleTitle=Lancet Neurol：多西环素治疗克-雅氏病疗效与安慰剂类似, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20f329839bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304313, encodeId=a7d7130431310, content=<a href='/topic/show?id=81724580886' target=_blank style='color:#2F92EE;'>#安慰剂#</a>, objectTitle=STM：医生对患者说的话也具有安慰剂效应？, objectType=article, longId=29244, objectId=056529244e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=056529244e7, replyNumber=0, likeNumber=79, createdTime=2014-01-12, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=056529244e7, moduleTitle=STM：医生对患者说的话也具有安慰剂效应？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=056529244e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304312, encodeId=6feb1304312ab, content=<a href='/topic/show?id=81724580886' target=_blank style='color:#2F92EE;'>#安慰剂#</a>, objectTitle=J Alzheimers Dis：阿尔茨海默病临床试验安慰剂效应解读, objectType=article, longId=27012, objectId=edde2e0127e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edde2e0127e, replyNumber=0, likeNumber=60, createdTime=2013-11-25, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edde2e0127e, moduleTitle=J Alzheimers Dis：阿尔茨海默病临床试验安慰剂效应解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=edde2e0127e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304311, encodeId=949e1304311d6, content=<a href='/topic/show?id=81724580886' target=_blank style='color:#2F92EE;'>#安慰剂#</a>, objectTitle=安慰剂效应与临床研究设计的关键注意点, objectType=article, longId=19040, objectId=bdfa19040d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bdfa19040d4, replyNumber=0, likeNumber=106, createdTime=2013-05-22, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bdfa19040d4, moduleTitle=安慰剂效应与临床研究设计的关键注意点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bdfa19040d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304310, encodeId=bd161304310c2, content=<a href='/topic/show?id=81724580886' target=_blank style='color:#2F92EE;'>#安慰剂#</a>, objectTitle=临床医生应如何正确使用安慰剂？, objectType=article, longId=19039, objectId=6a2a1903945, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a2a1903945, replyNumber=0, likeNumber=90, createdTime=2013-05-22, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a2a1903945, moduleTitle=临床医生应如何正确使用安慰剂？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a2a1903945)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304309, encodeId=b5a2130430948, content=<a href='/topic/show?id=81724580886' target=_blank style='color:#2F92EE;'>#安慰剂#</a>, objectTitle=安慰剂效应——Ted Kaptchuk找到了“假”药中的真成分, objectType=article, longId=19038, objectId=374b190383a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=374b190383a, replyNumber=0, likeNumber=97, createdTime=2013-05-22, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=374b190383a, moduleTitle=安慰剂效应——Ted Kaptchuk找到了“假”药中的真成分, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=374b190383a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304308, encodeId=7da81304308b2, content=<a href='/topic/show?id=81724580886' target=_blank style='color:#2F92EE;'>#安慰剂#</a>, objectTitle=NEJM：活性沙丁胺醇或安慰剂、假针灸或不干预在哮喘中作用, objectType=article, longId=2912, objectId=404c2912ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=404c2912ce, replyNumber=0, likeNumber=74, createdTime=2011-07-30, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=404c2912ce, moduleTitle=NEJM：活性沙丁胺醇或安慰剂、假针灸或不干预在哮喘中作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=404c2912ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304307, encodeId=3705130430ead, content=<a href='/topic/show?id=81724580886' target=_blank style='color:#2F92EE;'>#安慰剂#</a>, objectTitle=比较氟维司群与阿那曲唑治疗晚期乳腺癌的多中心、随机、双盲、双模拟、安慰剂对照的Ⅲ期临床试验, objectType=article, longId=2150, objectId=f5cf2150c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5cf2150c7, replyNumber=0, likeNumber=84, createdTime=2010-09-21, rootId=0, userName=wleon8895, userId=4cce318, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5cf2150c7, moduleTitle=比较氟维司群与阿那曲唑治疗晚期乳腺癌的多中心、随机、双盲、双模拟、安慰剂对照的Ⅲ期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5cf2150c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

安慰剂

2020-05-29

wleon8895 (审核中...)

前往app查看评论内容

#安慰剂#

NEJM：对于单纯性皮肤脓肿，复方新诺明优于安慰剂治疗

2016-03-04

wleon8895 (审核中...)

前往app查看评论内容

#安慰剂#

安慰剂效应：不仅仅是安慰，可能具有一定的客观效应

2016-02-12

wleon8895 (审核中...)

前往app查看评论内容

#安慰剂#

Nature：止痛剂药物研发面临安慰剂效应窘境

2015-10-13

wleon8895 (审核中...)

前往app查看评论内容

#安慰剂#

医生应该多使用安慰剂吗？

2015-01-09

wleon8895 (审核中...)

前往app查看评论内容

#安慰剂#

RECOURSE试验III期：TAS-102对比安慰剂治疗已给予更佳支持治疗且能耐受标准化疗的mCRC患者

2014-12-10

wleon8895 (审核中...)

前往app查看评论内容

#安慰剂#

FDA坚持安慰剂对照在埃博拉药物研制中不可省略

2014-11-13

wleon8895 (审核中...)

前往app查看评论内容

#安慰剂#

SCIENCE：揭开安慰剂治疗的假面

2014-10-12

wleon8895 (审核中...)

前往app查看评论内容

#安慰剂#

中医药随机对照临床试验安慰剂选择的探讨

2014-08-10

wleon8895 (审核中...)

前往app查看评论内容

#安慰剂#

小知识：反安慰剂效应临床研究中魔鬼

2014-05-15

wleon8895 (审核中...)

前往app查看评论内容

#安慰剂#

Lancet Neurol：多西环素治疗克-雅氏病疗效与安慰剂类似

2014-01-25

wleon8895 (审核中...)

前往app查看评论内容

#安慰剂#

STM：医生对患者说的话也具有安慰剂效应？

2014-01-12

wleon8895 (审核中...)

前往app查看评论内容

#安慰剂#

J Alzheimers Dis：阿尔茨海默病临床试验安慰剂效应解读

2013-11-25

wleon8895 (审核中...)

前往app查看评论内容

#安慰剂#

安慰剂效应与临床研究设计的关键注意点

2013-05-22

wleon8895 (审核中...)

前往app查看评论内容

#安慰剂#

临床医生应如何正确使用安慰剂？

2013-05-22

wleon8895 (审核中...)

前往app查看评论内容

#安慰剂#

安慰剂效应——Ted Kaptchuk找到了“假”药中的真成分

2013-05-22

wleon8895 (审核中...)

前往app查看评论内容

#安慰剂#

NEJM：活性沙丁胺醇或安慰剂、假针灸或不干预在哮喘中作用

2011-07-30

wleon8895 (审核中...)

前往app查看评论内容

#安慰剂#

比较氟维司群与阿那曲唑治疗晚期乳腺癌的多中心、随机、双盲、双模拟、安慰剂对照的Ⅲ期临床试验

2010-09-21

科室
- - 订阅+
  - 更多科室
工具
服务